Stem Cell-Derived Pancreatic Islet Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The shortage of pancreatic islet donors limits the effectiveness of pancreatic islet transplantation for diabetes treatment, necessitating alternative methods to produce transplantable islets that function similarly to endogenous islets.
Innovation Solution
The development of compositions and methods for producing stem cell-derived pancreatic islet cells by contacting pancreatic progenitor cells with specific media containing inhibitors and activators of signaling pathways, such as FoxO1, Notch, and Wnt pathways, to differentiate cells into NKX6.1-positive and ISL1-positive populations, which can be used to treat diabetes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pancreatic islet transplantation is used to treat diabetes, then the function of islet grafts can be maintained for years, but a shortage of pancreatic islet donors prevents effective implementation
Solution Approach 1:
The patent creates artificial pancreatic islets in the laboratory by differentiating stem cells into insulin-producing beta cells that replicate the structure and function of natural islets. This copying process eliminates dependence on donor organs while maintaining the functional characteristics and long-term viability of transplanted islets
Solution Approach 2:
The patent employs controlled changes in culture medium composition, including specific growth factors (insulin, IGF-1, Dexamethasone), signaling pathway modulators (Wnt, Notch, FoxO1 inhibitors), and cytokine profiles to direct stem cell differentiation. These parameter changes enable precise control over cell fate and islet formation, producing functional grafts without donor limitation
2Productivity
If stem cell-derived pancreatic islet cells are produced through in vitro differentiation, then a sustainable source for diabetes treatment is provided, but complex signaling pathway modulation is required
Solution Approach 1:
The patent divides the differentiation process into distinct temporal stages, each with specific media compositions and signaling pathway modulators. Early stages use one set of factors to establish basic cell identity, while later stages use different factors to refine beta cell characteristics and form functional islet structures. This segmentation simplifies control of the complex differentiation process
Solution Approach 2:
The patent introduces intermediary signaling pathway modulators (such as Wnt, Notch, and FoxO1 inhibitors) that act as mediators between stem cell pluripotency and terminal beta cell differentiation. These intermediaries control the transition through critical developmental windows, enabling reliable production of functional islets while managing process complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of in vitro differentiated cells that mimic native pancreatic islet function, potentially providing a sustainable source for diabetes treatment by effectively lowering blood glucose levels and improving insulin secretion responses.
Implementation Method 1
contacting pancreatic progenitor cells with a medium comprising a Forkhead Box O1 (FoxO1) inhibitor and a notch signaling pathway inhibitor
Implementation Method 2
contacting pancreatic progenitor cells with a medium comprising a Wnt signaling pathway inhibitor and a PKC activator
Data Source
AI summary
Disclosed herein are compositions and methods related to differentiation of stem cells into pancreatic islet cells. In some aspects, the methods provided herein relate to generation of pancreatic β cell, α cell, δ cells, and EC cells in vitro. In some aspects, the disclosure provides pharmaceutical compositions including the cells generated according to the methods disclosed herein, as well as methods of treatment making use thereof.